Stocks · News reference
Canaccord Genuity Acts as Sole Bookrunner for Annovis Bio Public Offering
Canaccord Genuity is serving as the sole bookrunner for a public offering by Annovis Bio, which is expected to generate approximately $21.0 million in gross proceeds.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CF Industries Holdings Q3 2026 Earnings Call Transcript
CF Industries Holdings (NYSE:CF) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
CF Industries Says Middle East Nitrogen Supply To Take Time To Flow Again Even If There Is Some Sort Of Resumption; Sees Robust Demand For UAN And Urea, Expects Positive Nitrogen Pricing Trajectory Through At Least H1 2027
CF Industries Expects Fall Ammonia Volumes Among Highest In 10 Years; Expects Global Nitrogen Supply Demand Balance To Remain Constructive Into 2027
Canaccord Genuity Group Inc. to Host MedTech, Diagnostics and Digital Health & Services Forum
Canaccord Genuity Group Inc. is hosting its MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026, in New York City.
Canaccord Genuity Group Inc. Schedules Second Quarter Fiscal 2027 Financial Results Release
Canaccord Genuity Group Inc. announced it will release its financial results for the second quarter of fiscal 2027 on November 10, 2026, followed by a conference call on November 11, 2026.